Skip to main content

Advertisement

Table 7 2/2 Cancer related traits from the GWAS Catalog v1.0 (release date: 2017-07-31)

From: Pipeline design to identify key features and classify the chemotherapy response on lung cancer patients using large-scale genetic data

Cancer related traits
Non-melanoma skin cancer
Non-small cell lung cancer
Non-small cell lung cancer (recurrence rate)
Non-small cell lung cancer (survival)
Obesity in adult survivors of childhood cancer exposed to cranial radiation
Obesity in adult survivors of childhood cancer not exposed to cranial radiation
Oral cavity and pharyngeal cancer
Oral cavity cancer
Oropharynx cancer
Ovarian cancer
Ovarian cancer in BRCA1 mutation carriers
Pancreatic cancer
Plasma androstenedione levels in resected early stage-receptor positive breast cancer
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer
Platinum-induced myelosuppression in non-small cell lung cancer
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)
Progression free survival in metastatic colorectal cancer (treatment interaction)
Prostate cancer
Prostate cancer (early onset)
Prostate cancer (interaction)
Prostate cancer (survival)
Prostate cancer aggressiveness
Pulmonary function
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)
Response to carboplatin in ovarian cancer (MTT IC50)
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Response to gemcitabine in pancreatic cancer
Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
Response to irinotecan in non-small-cell lung cancer
Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)
Response to paclitaxel in ovarian cancer (MTT IC50)
Response to Pazopanib in cancer (hepatotoxicity)
Response to platinum-based agents
Response to platinum-based chemotherapy (carboplatin)
Response to platinum-based chemotherapy (cisplatin)
Response to platinum-based chemotherapy in non-small-cell lung cancer
Response to platinum-based neoadjuvant chemotherapy in cervical cancer
Response to radiotherapy in cancer (late toxicity)
Response to radiotherapy in prostate cancer (overall toxicity)
Response to radiotherapy in prostate cancer (toxicity
Response to radiotherapy in prostate cancer (toxicity
Response to radiotherapy in prostate cancer (toxicity
Response to radiotherapy in prostate cancer (toxicity)
Response to tamoxifen in breast cancer
Small-cell lung cancer (survival)
Survival in colon cancer
Survival in colorectal cancer
Survival in colorectal cancer (distant metastatic)
Survival in colorectal cancer (non-distant metastatic)
Survival in endocrine treated breast cancer (estrogen-receptor positive)
Survival in head and neck cancer
Survival in microsatellite instability low/stable colorectal cancer
Survival in rectal cancer
Testicular cancer
Testicular germ cell cancer
Thyroid cancer
Thyroid cancer (Papillary
Urinary bladder cancer
Urinary symptoms in response to radiotherapy in prostate cancer